Literature DB >> 29778449

Mechanisms underlying the relaxation by A484954, a eukaryotic elongation factor 2 kinase inhibitor, in rat isolated mesenteric artery.

Tomoko Kodama1, Muneyoshi Okada1, Hideyuki Yamawaki2.   

Abstract

Eukaryotic elongation factor 2 kinase (eEF2K) is a calmodulin-related protein kinase which regulates protein translation. A484954 is an inhibitor of eEF2K. In the present study, we investigated the acute effects of A484954 on contractility of isolated blood vessels. Isometric contraction of rat isolated aorta and main branch of superior mesenteric artery (MA) was measured. Expression of an inward rectifier K+ (Kir) channel subtype mRNA and protein was examined. A484954 caused relaxation in endothelium-intact [E (+)] and -denuded [E (-)] aorta or MA precontracted with noradrenaline (NA). The relaxation was higher in MA than aorta. The relaxation was partially inhibited by a nitric oxide (NO) synthase inhibitor, NG-nitro-l-arginine methyl ester (300 μM) in E (+) MA. The relaxation was significantly smaller in MA precontracted with high K+ than NA. The A484954-induced relaxation was significantly inhibited by a Kir channel blocker, BaCl2 (1 mM) compared with vehicle control in E (-) MA. Expression of Kir2.2 mRNA and protein was significantly higher in MA than aorta. We for the first time revealed that A484954 induces relaxation through opening smooth muscle Kir (Kir2.2) channel and through endothelium-derived NO in MA.
Copyright © 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood vessel; K(+) channel; Vascular smooth muscle; Vasorelaxation

Mesh:

Substances:

Year:  2018        PMID: 29778449     DOI: 10.1016/j.jphs.2018.04.006

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  3 in total

1.  Eukaryotic elongation factor 2 kinase inhibitor, A484954 potentiates β-adrenergic receptor agonist-induced acute decrease in diastolic blood pressure in rats.

Authors:  Tomoko Kodama; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2019-09-05       Impact factor: 1.267

Review 2.  Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.

Authors:  Bin Zhang; Jiamei Zou; Qiting Zhang; Ze Wang; Ning Wang; Shan He; Yufen Zhao; C Benjamin Naman
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

3.  Age-dependent increase in activity of eukaryotic elongation factor 2 kinase in mesenteric arteries from spontaneously hypertensive rats.

Authors:  Tomoko Kodama; Kosuke Otani; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2020-11-16       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.